All ProductsDisplaying Products Alphabetically by Name (G)
| Cat. No. | Product Name / Activity |
|---|---|
| 5446 | G 28UCM |
| FASN inhibitor | |
| 6051 | G 5555 |
| High affinity group I PAK inhibitor | |
| 3577 | G-1 |
| Potent and selective GPER agonist | |
| 3678 | G-15 |
| High affinity and selective GPER antagonist | |
| 4759 | G-36 |
| Selective GPER antagonist | |
| 4131 | G418 disulfate salt |
| Aminoglycoside antibiotic; used in cell culture | |
| 6776 | G5 |
| Ubiquitin isopeptidase inhibitor; induces apoptosis | |
| 7561 | G6PDi 1 |
| Potent, reversible glucose-6-phosphate dehydrogenase (G6PD) inhibitor | |
| 0344 | GABA |
| Endogenous agonist | |
| 3191 | GANT 61 |
| GLI antagonist; inhibits Hedgehog (Hh) signaling | |
| 0513 | GBR 12783 dihydrochloride |
| Potent and selective DA uptake inhibitor | |
| 0421 | GBR 12909 dihydrochloride |
| Selective DA uptake inhibitor; also σ ligand | |
| 4554 | GC 1 |
| High affinity thyroid receptor α (TRα) and TRβ agonist; thyromimetic | |
| 4453 | GDC 0879 |
| Potent B-Raf inhibitor | |
| 0741 | GF 109203X |
| Protein kinase C inhibitor | |
| 8143 | GF-AFC New |
| Cell permeable fluorogenic substrate cleaved by cytosolic aminopeptidases for non-lytic high throughput cell viability assays | |
| 2430 | GGTI 298 |
| Geranylgeranyltransferase I (GGTase I) inhibitor | |
| 4452 | GGsTop |
| Inhibitor of γ-glutamyl transpeptidase (GGT) | |
| 1922 | [D-Lys3]-GHRP-6 |
| Ghrelin receptor antagonist | |
| 3995 | GI 254023X |
| Selective ADAM10 metalloprotease inhibitor | |
| 6689 | GI 530159 |
| K2P2.1 (TREK-1) and K2P10.1 (TREK-2) channel activator | |
| 2257 | GIP (1-39) |
| Highly potent insulinotropic peptide; GIP agonist | |
| 2084 | GIP (human) |
| Potent insulinotropic gut hormone; GIP agonist | |
| 6699 | [D-Ala2]-GIP (human) |
| Highly potent GIP agonist | |
| 5838 | [Pro3]-GIP (Mouse) |
| GIP receptor antagonist | |
| 3270 | GIT 27 |
| Immunomodulator; reduces production of pro-inflammatory cytokines | |
| 5133 | GKA 50 |
| Glucokinase activator | |
| 5374 | GLP-1 (7-37) |
| Endogenous bioactive GLP-1 receptor ligand | |
| 3266 | GLP-1 (9-36) amide |
| Metabolite of GLP-1-(7-36) (Cat. No. 2082) | |
| 7725 | GLP-2 (3-33) |
| Peptide antagonist of glucagon-like peptide-2 (GLP-2) receptor | |
| 2258 | GLP-2 (human) |
| Endogenous hormone; displays intestinotrophic activity | |
| 7059 | GLPG 0187 |
| Potent αv integrin inhibitor | |
| 5621 | GLPG 0974 |
| Potent FFA2 (GPR43) antagonist | |
| 3406 | GLYX 13 |
| NMDA partial agonist; acts at the glycine site | |
| 2983 | GM 6001 |
| Broad spectrum MMP inhibitor | |
| 7265 | GMB 475 |
| BCR-ABL1 kinase PROTAC® Degrader | |
| 5655 | GN 44028 |
| Potent HIF-1α inhibitor | |
| 6369 | GNE 9278 |
| Positive allosteric modulator of NMDA receptors; acts in transmembrane domain | |
| 4908 | GNF 5 |
| Selective allosteric inhibitor of Bcr-Abl; analog of GNF 2 (Cat. No. 4399) | |
| 4559 | GNF 5837 |
| Potent Trk inhibitor; inhibits TrkA, TrkB and TrkC | |
| 5607 | GNF 7 |
| Ras signaling inhibitor; inhibits Ack1 and GCK | |
| 2764 | GP 1a |
| CB2 receptor inverse agonist | |
| 4478 | GPBAR-A |
| GPBA receptor (TGR5) agonist | |
| 7445 | GPR52 Comp-43 |
| GPR52 receptor antagonist | |
| 1322 | GR 113808 |
| Potent and selective 5-HT4 antagonist | |
| 1658 | GR 125487 sulfamate |
| Potent and selective 5-HT4 antagonist; active in vivo | |
| 1477 | GR 127935 hydrochloride |
| Potent and selective 5-HT1B and 5-HT1D antagonist | |
| 1263 | GR 144053 trihydrochloride |
| Glycoprotein IIb/IIIa (integrin αIIbβ3) receptor antagonist. Antithrombotic | |
| 4647 | GR 203040 |
| Potent and selective NK1 antagonist | |
| 1054 | GR 55562 dihydrochloride |
| 5-HT1B antagonist | |
| 1668 | GR 64349 |
| Potent, selective NK2 agonist | |
| 1669 | GR 73632 |
| Potent and selective NK1 agonist | |
| 1483 | GR 89696 fumarate |
| Subtype-selective κ agonist | |
| 4779 | GRI 977143 |
| Selective LPA2 receptor non-lipid agonist | |
| 7280 | GRL 0617 |
| Coronavirus PLpro inhibitor | |
| 1789 | GRP (human) |
| Endogenous GRP receptor agonist | |
| 5636 | GS 143 |
| β-TrCP1 ligase inhibitor | |
| 2001 | GS 39783 |
| Positive allosteric modulator of GABAB receptors | |
| 7227 | GS 441524 |
| Viral RNA-dependent RNA polymerase (RdRP) inhibitor; broad spectrum antiviral nucleotide | |
| 4727 | GS 6201 |
| Selective A2B antagonist | |
| 3433 | GSK 0660 |
| Selective PPARδ antagonist | |
| 6433 | GSK 1016790A |
| Potent TRPV4 agonist; active in vivo | |
| 6790 | GSK 126 |
| Very high affinity and selective EZH2 inhibitor | |
| 6362 | GSK 143 |
| Syk inhibitor | |
| 5110 | GSK 1562590 hydrochloride |
| High affinity, selective urotensin II (UT) receptor antagonist | |
| 6508 | GSK 1702934A |
| Potent and selective TRPC3/6 activator | |
| 5111 | GSK 1838705 |
| Potent IR and IGF1R inhibitor; also inhibits anaplastic lymphoma kinase (ALK) | |
| 6709 | GSK 2018682 |
| S1P1 and S1P5 agonist | |
| 5694 | GSK 2033 |
| Potent LXR antagonist | |
| 7818 | GSK 215 |
| Potent and selective focal adhesion kinase (FAK) Degrader (PROTAC®) | |
| 5106 | GSK 2193874 |
| Potent and selective TRPV4 antagonist; orally active | |
| 5303 | GSK 2194069 |
| Potent human fatty acid synthase (hFASN) inhibitor | |
| 7071 | GSK 2239633A |
| Potent CCR4 antagonist | |
| 5401 | GSK 2250665A |
| Itk inhibitor | |
| 7786 | GSK 2256098 |
| Potent focal adhesion kinase (FAK) inhibitor | |
| 4143 | GSK 2334470 |
| Highly potent, selective PDPK1 (PDK1) inhibitor | |
| 5107 | GSK 2606414 |
| Potent and selective PERK inhibitor; orally bioavailable | |
| 3752 | GSK 264220A |
| Endothelial lipase and lipoprotein lipase inhibitor | |
| 4009 | GSK 269962 |
| Potent and selective ROCK inhibitor | |
| 6848 | GSK 2795039 |
| NADPH oxidase 2 (NOX2) inhibitor | |
| 5140 | GSK 2830371 |
| Potent and selective allosteric inhibitor of Wip1 phosphatase | |
| 6497 | GSK 2833503A |
| Potent and selective TRPC6 and TRPC3 antagonist | |
| 5189 | GSK 2837808A |
| Potent and selective LDHA inhibitor | |
| 5672 | GSK 319347A |
| Potent and selective IKKε inhibitor | |
| 7637 | GSK 329 |
| Potent and selective TNNI3K inhibitor, orally bioavailable | |
| 6128 | GSK 343 |
| Potent and selective SAM-competitive EZH2 inhibitor | |
| 3961 | GSK 3787 |
| Potent and selective PPARδ antagonist | |
| 3663 | GSK 4112 |
| Selective Rev-Erbα agonist | |
| 3726 | GSK 429286 |
| Selective Rho-kinase (ROCK) inhibitor | |
| 3075 | GSK 4716 |
| Selective ERRγ and ERRβ agonist | |
| 6480 | GSK 583 |
| Potent RIPK2 inhibitor; orally bioavailable and cell permeable | |
| 5777 | GSK 591 dihydrochloride |
| Potent and selective PRMT5 inhibitor | |
| 6638 | GSK 626616 |
| Potent and selective DYRK inhibitor; orally bioavailable. | |
| 3572 | GSK 650394 |
| Serum- and glucocorticoid-regulated kinase (SGK) inhibitor | |
| 6198 | GSK 6853 |
| Potent and selective BRPF1 inhibitor | |
| 4144 | GSK 690693 |
| Akt kinase inhibitor. Antitumor | |
| 4116 | GSK 9027 |
| Glucocorticoid receptor agonist | |
| 6203 | GSK 9311 hydrochloride |
| Negative control for GSK 6853 | |
| 4593 | GSK J1 |
| Potent JMJD3/UTX inhibitor | |
| 4688 | GSK J2 |
| Inactive isomer of GSK J1 (Cat. No. 4593) | |
| 4594 | GSK J4 |
| Histone KDM inhibitor; cell permeable | |
| 6935 | GSK J5 HCl |
| Inactive isomer of GSK J4 (Cat. No. 4594); cell permeable | |
| 5361 | GSK LSD 1 dihydrochloride |
| Potent and selective LSD1 inhibitor | |
| 4629 | GSK2578215A |
| Potent, selective LRRK2 inhibitor; brain penetrant | |
| 6492 | GSK'872 |
| Potent and selective RIP3 kinase inhibitor | |
| 6578 | GT 949 |
| Potent and selective positive allosteric modulator of EAAT2 | |
| 2229 | GW 0742 |
| Highly selective, potent PPARδ agonist | |
| 1664 | GW 1929 hydrochloride |
| Selective PPARγ agonist. Orally active | |
| 5673 | GW 2580 |
| Selective cFMS kinase inhibitor; orally bioavailable | |
| 7030 | GW 280264X |
| Potent ADAM10 and ADAM17 inhibitor | |
| 2474 | GW 3965 hydrochloride |
| Orally active liver X receptor (LXR) agonist | |
| 2473 | GW 4064 |
| Selective farnesoid X receptor (FXR) agonist | |
| 2238 | GW 441756 |
| Potent, selective TrkA inhibitor | |
| 6741 | GW 4869 |
| Selective neutral sphingomyelin phosphodiesterase (N-SMase) inhibitor | |
| 5674 | GW 501516 |
| Potent and selective PPARδ agonist | |
| 1381 | GW 5074 |
| Potent, selective c-Raf1 kinase inhibitor | |
| 4311 | GW 542573X |
| Selective KCa2.1 (SK) channel activator | |
| 2239 | GW 583340 dihydrochloride |
| Potent dual EGFR/ErbB2 inhibitor; orally active | |
| 4618 | GW 6471 |
| PPARα antagonist | |
| 1677 | GW 7647 |
| Highly selective, potent PPARα agonist. Orally active | |
| 3264 | GW 788388 |
| Potent and selective inhibitor of TGF-βRI | |
| 4242 | GW 803430 |
| MCH1 antagonist | |
| 2977 | GW 843682X |
| Selective inhibitor of PLK1 and PLK3 | |
| 2649 | GW 9508 |
| Potent and selective FFA1 (GPR40) agonist | |
| 1508 | GW 9662 |
| Selective covalent PPARγ antagonist | |
| 7029 | GX 201 |
| Potent and selective Nav1.7 blocker; analgesic | |
| 1454 | GYKI 52466 dihydrochloride |
| Selective non-competitive AMPA antagonist | |
| 2555 | GYKI 53655 hydrochloride |
| Non-competitive non-NMDA iGluR antagonist | |
| 3658 | GYY 4137 morpholine salt |
| Slow-releasing H2S donor | |
| 1798 | Gabexate mesylate |
| Serine protease inhibitor; inhibits thrombin, trypsin, kallikrein and plasmin | |
| 4741 | Gadolinium chloride |
| Stretch-activated calcium channel blocker; calcium-sensing receptor agonist | |
| 7780 | β-GalNAc-PEG4-Azide |
| Asialoglycoprotein receptor ligand with PEG4 linker and azide group for onward chemistry | |
| 2696 | Galanin (1-29) (rat, mouse) |
| Non-selective galanin receptor agonist | |
| 1179 | Galanin (1-30) (human) |
| Endogenous galanin receptor agonist | |
| 0686 | Galanthamine hydrobromide |
| Cholinesterase inhibitor | |
| 6108 | Galeterone |
| CYP17 inhibitor; also androgen receptor antagonist | |
| 7229 | Galidesivir dihydrochloride |
| Viral RNA-dependent RNA polymerase (RdRP) inhibitor; broad spectrum antiviral | |
| 3090 | Gallein |
| Inhibitor of Gβ/γ signaling | |
| 4795 | Galloflavin |
| Lactate dehydrogenase inhibitor; impairs aerobic glycolysis | |
| 6956 | Galunisertib |
| ALK4 and ALK5 (TGFβRI) inhibitor | |
| 2531 | Ganaxolone |
| Potent positive allosteric modulator of GABAA receptors | |
| 1476 | Gap 27 |
| Selective gap junction blocker | |
| 5353 | Gap19 |
| Cx43 hemichannel blocker | |
| 3006 | Gastrin I (human) |
| Selective CCK2 agonist | |
| 2348 | Gavestinel |
| Potent and selective NMDA antagonist; acts at the glycine site | |
| 6795 | GeA-69 |
| Selective allosteric PARP14 inhibitor | |
| 3387 | Gedunin |
| Hsp90 inhibitor; exhibits anticancer and antimalarial activity | |
| 7258 | Gefitinib-based PROTAC® 3 |
| Potent EGFR PROTAC® Degrader | |
| 1368 | Geldanamycin |
| Selective Hsp90 inhibitor | |
| 3259 | Gemcitabine hydrochloride |
| DNA synthesis inhibitor | |
| 1110 | Genistein |
| EGFR kinase inhibitor. Also estrogen and PPARγ ligand | |
| 6442 | Gentamicin sulfate |
| Aminoglycoside antibiotic | |
| 1463 | Ghrelin (human) |
| Endogenous ghrelin receptor agonist | |
| 1465 | Ghrelin (rat) |
| Endogenous ghrelin receptor agonist | |
| 7891 | Gilteritinib |
| Potent FLT3 inhibitor; also potently inhibits AXL | |
| 4165 | Gisadenafil besylate |
| Potent PDE5 inhibitor; orally bioavailable | |
| 6249 | Givinostat hydrochloride |
| Histone deacetylase inhibitor | |
| 0911 | Glibenclamide |
| Kir6 (KATP) channel blocker | |
| 2216 | des-His1-[Glu9]-Glucagon (1-29) amide |
| Glucagon receptor antagonist | |
| 6927 | Glucagon (Human, Porcine) |
| Endogenous glucagon receptor agonist | |
| 1851 | Glucagon-like peptide 1 (1-37) (human, rat) |
| Endogenous pancreatic peptide | |
| 2082 | Glucagon-like peptide 1 (7-36) amide (human, rat) |
| Potent insulinotropic peptide | |
| 0218 | L-Glutamic acid |
| Endogenous, non-selective glutamate receptor agonist | |
| 5485 | GlyH 101 |
| Reversible, voltage-dependent CFTR chloride channel blocker | |
| 0219 | Glycine |
| Endogenous potentiator of NMDA receptors | |
| 2253 | Go 6976 |
| Potent protein kinase C inhibitor; selective for α and β isozymes | |
| 2285 | Go 6983 |
| Broad spectrum PKC inhibitor | |
| 5814 | GoSlo SR 5-69 |
| KCa1.1 (BK) channel activator | |
| 3584 | Golgicide A |
| Potent, selective and reversible inhibitor of GBF1 ArfGEF | |
| 1964 | Gossypol |
| Proapoptotic; downregulates Bcl-2 and Bcl-XL | |
| 2903 | Granisetron hydrochloride |
| 5-HT3 antagonist | |
| 4581 | Grifolic acid |
| Selective partial FFA4 (GPR120) agonist | |
| 4912 | GsMTx4 |
| TRPC1 and TRPC6 inhibitor; inhibits mechanosensitive ion channels | |
| 7170 | D-GsMTx4 |
| TRPC1/6 and Piezo2 inhibitor; resistant to proteolytic digestion | |
| 0885 | Guanabenz acetate |
| α2 agonist. Also I2 selective ligand | |
| 1030 | Guanfacine hydrochloride |
| α2A agonist | |
| 5676 | Guangxitoxin 1E |
| Potent Kv2.1 and Kv2.2 channel blocker | |
| 1898 | Guanylin (human) |
| Endogenous activator of intestinal guanylyl cyclase | |
| 3570 | Z-Guggulsterone |
| Broad spectrum steroid receptor ligand. More active isomer of guggulsterone (Cat. No. 2013) |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800